packageBosutinib

bosutinib

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Bosutinib is a protein kinase inhibitor used to treat leukemia, specifically myeloid leukemia. It is authorised in the European Union and is an approved medicine.

Summary written by glm-5.3-flash from Wikidata Q894611 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:bosutinib
ATC codes:L01EA04
DrugBank:DB06616
PubChem CID:5328940
ChEBI:39112
Wikidata:Q894611
formula:C26H29Cl2N5O3
molar mass:530.45 g/mol (PubChem CID 5328940)
logP:5.4 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown